[CRVS] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
29-Oct-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 15.21%
YoY- -4.82%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -10,611 -12,935 -11,047 -11,004 -12,978 -11,643 -10,509 0.64%
Tax 0 0 -185 -186 0 0 -180 -
NP -10,611 -12,935 -11,047 -11,004 -12,978 -11,643 -10,509 0.64%
Tax Rate - - - - - - - -
Total Cost 10,611 12,935 11,047 11,004 12,978 11,643 10,509 0.64%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.36 -0.44 -0.38 -0.37 -0.44 -0.40 -0.36 0.00%
EPS Diluted -0.36 -0.44 -0.38 -0.37 -0.44 -0.40 -0.36 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.